Company profile
Kaya Holdings, Inc. CIK 1530746
Ticker
KAYS (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Fort Lauderdale, FL 33304
Fiscal year end
2024 (FY)
Key Financials
Revenue
$7.1K
Net income
-$2.08M
Total assets
$216.4K
Total liabilities
$17.34M
Stockholders' equity
-$15.03M
Cash & equivalents
$39.7K
Operating income
-$2.02M
Operating cash flow
-$830.8K
Capital expenditures
$27.1K
Fiscal year 2024, via 10-K/A filed 2025-05-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-28,343.5%
Net margin
-29,168.2%
Free cash flow
-$858.0K
Free cash flow margin
-12,026.3%
Liabilities / assets
8,016.2%
Equity / assets
-6,946.5%
CapEx / revenue
380.4%
Operating cash flow / net income
0.40×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
$7.1K
-$2.08M
$216.4K
$17.34M
-$15.03M
2023
$196.3K
$1.61M
$215.9K
$15.97M
-$13.80M
2022
$685.4K
-$3.58M
$843.2K
$18.45M
-$17.60M
2021
$889.9K
$9.72M
$1.57M
$15.98M
-$14.41M
2020
$1.03M
-$12.30M
$2.30M
$27.22M
-$23.40M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form NT 10-K
2026-03-30
Financials filed via
Form 10-K/A
filed 2025-05-19
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Fort Lauderdale, FL 33304
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.